Compare Abeona Therapeutics Inc (ABEO) vs Norfolk Southern Corporation (NSC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Norfolk Southern Corporation — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Norfolk Southern Corporation trades at $333.81 (market cap $75.15B). The key difference: Norfolk Southern Corporation is far larger — about 178.4× Abeona Therapeutics Inc's market cap, and Norfolk Southern Corporation pays a 1.61% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | NSC | |
|---|---|---|
Market Cap | $421.19M | $75.15B |
Sector | Health | Technology |
52-Week High | $7.45 | $350.66 |
52-Week Low | $4.17 | $272.35 |
Enterprise Value | $276.10M | $90.70B |
Dividend Yield | — | 1.61% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Norfolk Southern Corporation
Norfolk Southern Corporation is a major North American railroad company operating one of the largest freight rail networks in the eastern United States. The company transports a diverse range of commodities, including coal, intermodal containers, and various industrial products. NSC is a critical link in the nation's supply chain, providing efficient, long-haul transportation services to and from ports and industrial centers.
Read more on NSC →
